NX Development Corp. Email Format

Pharmaceutical ManufacturingKentucky, United States11-50 Employees

NX Development Corp. is a pharmaceutical manufacturing company based in Lexington, Kentucky, focused on visualizing cancer in novel ways. Its flagship product Gleolan is an optical imaging agent used to assist surgeons in identifying malignant tissue during brain tumor procedures, notably high-grade gliomas, by highlighting cancerous tissue to aid operative visualization. The company appears to position itself within the life sciences sector by delivering a product that supports intraoperative decision-making for oncologic surgeries, potentially impacting surgical outcomes. NX Development Corp. operates with a relatively small to mid-sized team and conducts its activities from its Lexington location, as indicated by its address and stated industry, with a clear emphasis on bringing clinically useful imaging agents to the U.S. market. A notable recent development is the U.S. commercial launch of Gleolan in 2018 and again in 2019, reflecting ongoing progress in expanding access to its imaging agent for surgical use.

Get verified NX Development Corp. emails free

Company overview Employee directory